Skip to main content
. 2008 Mar 11;5(3):e53. doi: 10.1371/journal.pmed.0050053

Figure 2. Improvements in Life Expectancy at Infection Due to the Availability of ART.

Figure 2

In (A) only symptoms are used to initiate ART (rule 1); in (B) one CD4+ cell count measurement is used in the way WHO recommend (rule 7). In both panels, 5% yearly drop-out rate is assumed.